Regulations.gov document
Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer…
Notice · FDA-2017-N-2936 · posted Aug 21, 2017
Key facts
| Document ID | FDA-2017-N-2936-0002 |
|---|---|
| Title | Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Establishment of a Public Docket; Request for Information and Comments |
| Document type | Notice |
| Subtype | Announcement |
| Agency | FDA |
| Docket | FDA-2017-N-2936 |
| Posted | Aug 21, 2017 |
| Federal Register citation | 82 FR 39598 |
| FR document number | 2017-17563 |
| Comment period opens | Aug 21, 2017 |
| Comments due | Nov 21, 2017 |
| Effective date | Aug 21, 2017 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: